Baxter International Inc
A maker of essential hospital supplies, Baxter produces sterile IV solutions, infusion pumps, parenteral nutrition, surgical sealants, smart beds, and patient monitors sold in dozens of countries. Founded in 1931 by Dr. Donald Baxter and surgeon Ralph Falk, the company created the first factory-made sterile IV solutions in vacuum-sealed glass containers, replacing the contaminated hand-mixed fluids hospitals once brewed themselves. In 2025 it sold its Kidney Care business, Vantive.
Granted 569.9K
Granted 346.4K
Granted 301.5K
Granted 270.4K · Sold 178.1K
Granted 46.4K
Granted 165.5K
Granted 170.5K
Granted 128.7K
Granted 128.5K
Granted 225.4K
Granted 59.7K
Granted 20.5K
Granted 26.0K
Granted 102.1K
Granted 72.3K
Granted 55.9K · Sold 2.5K
Granted 61.4K
Granted 34.4K · Sold 21.4K
Granted 33.3K
Granted 33.3K
Granted 10.7K · Sold 8.0K
Granted 33.3K
Granted 20.4K
Granted 34.0K
Granted 6.7K · Sold 4.0K
Granted 19.0K
Granted 29.8K
Granted 20.4K
Granted 7.3K
Granted 16.1K
Granted 3.0K · Sold 3.0K
Granted 4.4K · Sold 1.7K
Granted 23.5K
Granted 23.9K · Sold 3.8K
Granted 12.9K
Granted 16.2K
Granted 14.6K
Granted 13.0K
Granted 29.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Hider Andrew P.President and CEO, Director · 3 transactions | — | 572.2K | 569.9K | — | — |
| Almeida Jose EChairman, CEO, President · 14 transactions | — | 568.6Kas of Dec 2024 | 346.4K | — | — |
| Grade Joel T.EVP and CFO · 12 transactions | — | 271.7K | 301.5K | — | — |
| Mason Jeanne KEVP, Chief HR Officer · 24 transactions | +70.8% | 199.9K | 270.4K | — | 178.1K |
| Saccaro JamesEVP, Chief Financial Officer · 9 transactions | +4.4% | 177.9Kas of Mar 2023 | 46.4K | — | — |
| Knight HeatherEVP, Chief Operating Officer · 13 transactions | — | 177.4Kas of Mar 2025 | 165.5K | — | — |
| Rosenbloom David S.EVP and General Counsel · 16 transactions | — | 138.2K | 170.5K | — | — |
| Sonig AlokEVP,Group President,Pharma · 9 transactions | — | 128.2K | 128.7K | — | — |
| Rasul ReazurEVP,Group Pres,Healthcare · 11 transactions | — | 125.6K | 128.5K | — | — |
| Toth Christopher A.EVP, Group Pres, Kidney Care · 5 transactions | — | 105.2Kas of Jan 2025 | 225.4K | — | — |
| Franzi CristianoSVP, President, EMEA · 9 transactions | +144.7% | 102.1Kas of Mar 2023 | 59.7K | — | — |
| Accogli GiuseppeEVP, Chief Operating Officer · 5 transactions | +10.6% | 76.5Kas of Mar 2022 | 20.5K | — | — |
| Soriano Maria CeciliaGroup Pres., ITT & Pharma. · 5 transactions | — | 75.0K | 26.0K | — | — |
| Shafer David BrentDirector, Chair of the Board · 6 transactions | — | 72.8K | 102.1K | — | — |
| Borzi James WEVP,Chief Supply Chain Officer · 15 transactions | — | 71.9K | 72.3K | — | — |
| Wallace Steven P.President, Adv. Surgery · 1 transaction | — | 70.1K | — | — | — |
| Stevens BrianSVP, CAO & Controller · 24 transactions | +258.2% | 67.5Kas of Mar 2024 | 55.9K | — | 2.5K |
| Zielinski Anita ASVP, Interim CFO, CAO & Cntrlr · 4 transactions | — | 59.7K | 61.4K | — | — |
| Martin SeanSVP and General Counsel · 7 transactions | -15.1% | 52.6Kas of Mar 2022 | 34.4K | — | 21.4K |
| Wendell Amy McBrideDirector · 5 transactions | +326.8% | 44.2K | 33.3K | — | — |
| Morrison PatriciaDirector · 5 transactions | +475.1% | 42.4K | 33.3K | — | — |
| Stroucken Albert P LDirector · 6 transactions | — | 38.2Kas of Mar 2023 | 10.7K | — | 8.0K |
| Wilkes David S.Director · 5 transactions | +1327.6% | 37.1K | 33.3K | — | — |
| Oesterle Stephen N.Director · 4 transactions | +165.6% | 35.8Kas of May 2025 | 20.4K | — | — |
| Schlichting Nancy MDirector · 6 transactions | — | 35.0K | 34.0K | — | — |
| Hellman Peter SDirector · 4 transactions | +9.4% | 31.5Kas of May 2022 | 6.7K | — | 4.0K |
| Flynn StevenSVP, President, APAC · 3 transactions | — | 31.1Kas of Mar 2023 | 19.0K | — | — |
| Teaff JamesPresident, CCS · 1 transaction | — | 31.1K | — | — | — |
| Ampofo William A. IIDirector · 4 transactions | — | 30.4K | 29.8K | — | — |
| Smith Cathy RDirector · 4 transactions | +258.1% | 30.3Kas of May 2025 | 20.4K | — | — |
| Mahoney Michael FDirector · 2 transactions | +32.8% | 30.1Kas of May 2023 | 7.3K | — | — |
| Rasul ReazEVP, Group Pres, Healthcare · 6 transactions | — | 27.9Kas of Feb 2024 | 16.1K | — | — |
| Forsyth John DDirector · 6 transactions | +1% | 27.0Kas of Apr 2022 | 3.0K | — | 3.0K |
| Chen Thomas FDirector · 3 transactions | +13.1% | 24.9Kas of May 2022 | 4.4K | — | 1.7K |
| Craig Jeffrey ADirector · 3 transactions | — | 23.7K | 23.5K | — | — |
| Kunzler JacquelineSVP, Chief Quality Officer · 14 transactions | +286.5% | 22.6Kas of Mar 2023 | 23.9K | — | 3.8K |
| Frye AndrewSVP, President, APAC · 3 transactions | +143.4% | 22.0Kas of Mar 2022 | 12.9K | — | — |
| Rusckowski Stephen HDirector · 3 transactions | — | 16.5Kas of May 2025 | 16.2K | — | — |
| McDonnell Michael R.Director · 2 transactions | — | 14.6K | 14.6K | — | — |
| Wilver Peter MDirector · 3 transactions | — | 13.3Kas of May 2024 | 13.0K | — | — |
| Carlisle CynthiaExecutive Vice President, CHRO · 2 transactions | — | 0 | 29.7K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -222.5K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.